Wealthspire Advisors (New York)’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
+2,174
New +$577K 0.01% 548
2025
Q4
– Sell
-268
Closed -$52.5K – 2972
2025
Q3
$52.5K Buy
+268
New +$44.1K ﹤0.01% 1233

Other funds holding ALAB

Wealthspire Advisors (New York)'s ALAB Position: Q2 2026 in Review

Wealthspire Advisors (New York) opened a new position in Astera Labs (ALAB) in Q2 2026: 2,174 shares worth $1.05M. The stake represents 0.01% of the portfolio and ranks #548 among its holdings. This is a return to the name: Wealthspire Advisors (New York) previously reported a position in ALAB as recently as Q3 2025.

Wealthspire Advisors (New York) first reported a position in ALAB in Q3 2025 and has held it in 2 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Wealthspire Advisors (New York) held 2,174 shares of Astera Labs worth $1.05M as of Q2 2026.
  • Astera Labs was a new Wealthspire Advisors (New York) position in Q2 2026.
  • Astera Labs made up 0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #548 holding.
  • Wealthspire Advisors (New York) first reported a position in Astera Labs in Q3 2025 and has held it in 2 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.